Jim Burns reunites with Genzyme colleague at Ensoma; Lilly exec to retire after 27 years
Jim Burns was looking for his next post after his latest venture in biotech, a gene therapy startup known as Locanabio, shut down “due to the time and capital required to deliver clinical data.” “I felt like there was some unfinished …